Matches in Wikidata for { <http://www.wikidata.org/entity/Q120203483> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q120203483 description "article scientifique publié en 2022" @default.
- Q120203483 description "artículu científicu espublizáu en 2022" @default.
- Q120203483 description "scientific article published in 2022" @default.
- Q120203483 description "наукова стаття, опублікована у 2022" @default.
- Q120203483 name "870. Olorofim for the treatment of invasive mould infections in patients with limited or no treatment options: Comparison of interim results from a Phase 2B open-label study with outcomes in historical control populations (NCT03583164, FORMULA-OLS," @default.
- Q120203483 type Item @default.
- Q120203483 label "870. Olorofim for the treatment of invasive mould infections in patients with limited or no treatment options: Comparison of interim results from a Phase 2B open-label study with outcomes in historical control populations (NCT03583164, FORMULA-OLS," @default.
- Q120203483 prefLabel "870. Olorofim for the treatment of invasive mould infections in patients with limited or no treatment options: Comparison of interim results from a Phase 2B open-label study with outcomes in historical control populations (NCT03583164, FORMULA-OLS," @default.
- Q120203483 P1433 Q120203483-28123443-1E71-4E7C-9C3A-7263F6D72A9C @default.
- Q120203483 P1476 Q120203483-99BC88AE-B3FE-4BCD-979C-372E0B54D6B2 @default.
- Q120203483 P2093 Q120203483-159DBD52-AD12-42F3-B85E-2F548A872EBA @default.
- Q120203483 P2093 Q120203483-824F5274-3EC0-4F61-A61E-4D97E1D4B3D1 @default.
- Q120203483 P2093 Q120203483-82FD6EBB-A375-4BC8-B3A5-143C35492D32 @default.
- Q120203483 P2093 Q120203483-839030CA-7FC5-4768-B0C2-30B01FE60626 @default.
- Q120203483 P2093 Q120203483-8C4C5EAC-D82A-4CAE-80EC-04552AB4AAC3 @default.
- Q120203483 P2093 Q120203483-A82B6D73-2A49-435C-86A2-04A785849593 @default.
- Q120203483 P2093 Q120203483-DB06B97F-667D-464C-B539-9362115B6C86 @default.
- Q120203483 P2093 Q120203483-F9826760-4E31-4A39-833D-F8D9FD692EF3 @default.
- Q120203483 P31 Q120203483-ED9C65AF-F9C7-4659-BE2B-718739E9189F @default.
- Q120203483 P356 Q120203483-0536157A-894B-4CF6-87B2-B64ED58207E9 @default.
- Q120203483 P433 Q120203483-A0E24DD3-A75B-4521-A150-68B734C34631 @default.
- Q120203483 P478 Q120203483-E6931DBA-C7C5-45A1-AA47-EC9D4ADC1EAB @default.
- Q120203483 P577 Q120203483-C65A7794-316E-4D40-B0BD-8C4DFF6AAF97 @default.
- Q120203483 P356 OFAC492.063 @default.
- Q120203483 P1433 Q27725953 @default.
- Q120203483 P1476 "870. Olorofim for the treatment of invasive mould infections in patients with limited or no treatment options: Comparison of interim results from a Phase 2B open-label study with outcomes in historical control populations (NCT03583164, FORMULA-OLS, Study 32)" @default.
- Q120203483 P2093 "Aaron Dane" @default.
- Q120203483 P2093 "Daniela Zinzi" @default.
- Q120203483 P2093 "Emma L Harvey" @default.
- Q120203483 P2093 "Evan F Lanuza" @default.
- Q120203483 P2093 "Johan A Maertens" @default.
- Q120203483 P2093 "John H Rex" @default.
- Q120203483 P2093 "Paul E Verweij" @default.
- Q120203483 P2093 "Sharon C Chen" @default.
- Q120203483 P31 Q13442814 @default.
- Q120203483 P356 "10.1093/OFID/OFAC492.063" @default.
- Q120203483 P433 "Supplement_2" @default.
- Q120203483 P478 "9" @default.
- Q120203483 P577 "2022-12-01T00:00:00Z" @default.